These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1904303

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA.
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [Abstract] [Full Text] [Related]

  • 24. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001 Oct; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA, Pato MT, L'Heureux F, Hill JL, Grover GN, Bernstein SE, Murphy DL.
    J Clin Psychopharmacol; 1991 Aug; 11(4):242-8. PubMed ID: 1918422
    [Abstract] [Full Text] [Related]

  • 27. Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine.
    Bauer M, Linden M, Schaaf B, Weber HJ.
    J Clin Psychopharmacol; 1996 Apr; 16(2):130-4. PubMed ID: 8690828
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lithium augmentation in geriatric depression.
    van Marwijk HW, Bekker FM, Nolen WA, Jansen PA, van Nieuwkerk JF, Hop WC.
    J Affect Disord; 1990 Dec; 20(4):217-23. PubMed ID: 2149727
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG, Thatte S, Wiggins D.
    Psychopharmacol Bull; 1990 Dec; 26(3):285-90. PubMed ID: 2274627
    [Abstract] [Full Text] [Related]

  • 32. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC, Price LH.
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract] [Full Text] [Related]

  • 33. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ, Stagno SJ, Calabrese JR.
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anorexia nervosa, major depression, and obsessive-compulsive disorder in a Down's syndrome patient.
    Raitasuo S, Virtanen H, Raitasuo J.
    Int J Eat Disord; 1998 Jan; 23(1):107-9. PubMed ID: 9429927
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Low dose potency of lithium in antidepressant augmentation.
    Madakasira S.
    Psychiatr J Univ Ott; 1986 Jun; 11(2):107-9. PubMed ID: 3090579
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.